Renaissance Technologies - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 69 filers reported holding CTI BIOPHARMA CORP in Q1 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q3 2022$154,000
-94.2%
26,520
-94.0%
0.00%
-100.0%
Q2 2022$2,648,000
-49.0%
443,613
-60.1%
0.00%
-50.0%
Q1 2022$5,190,000
+54.4%
1,111,413
-18.0%
0.01%
+50.0%
Q4 2021$3,361,000
-36.3%
1,355,413
-24.3%
0.00%
-42.9%
Q3 2021$5,279,000
-13.4%
1,789,498
-26.6%
0.01%
-12.5%
Q2 2021$6,096,000
+30.1%
2,438,433
+51.4%
0.01%
+33.3%
Q1 2021$4,687,000
-19.1%
1,610,813
-10.5%
0.01%0.0%
Q4 2020$5,793,000
+22.7%
1,799,171
-18.1%
0.01%
+20.0%
Q3 2020$4,721,000
+93.5%
2,195,607
+4.4%
0.01%
+150.0%
Q2 2020$2,440,000
+27.1%
2,103,792
+0.8%
0.00%0.0%
Q1 2020$1,919,000
-38.3%
2,086,124
+6.0%
0.00%0.0%
Q4 2019$3,109,000
+97.8%
1,967,914
+4.8%
0.00%
+100.0%
Q3 2019$1,572,000
+14.6%
1,877,889
+17.6%
0.00%0.0%
Q2 2019$1,372,000
+10.3%
1,596,587
+24.5%
0.00%0.0%
Q1 2019$1,244,000
+55.9%
1,282,352
+17.9%
0.00%0.0%
Q4 2018$798,000
-51.5%
1,087,249
+42.8%
0.00%
-50.0%
Q3 2018$1,645,000
-74.8%
761,561
-47.9%
0.00%
-50.0%
Q2 2018$6,539,000
+143.4%
1,462,390
+112.3%
0.00%
+33.3%
Q1 2018$2,687,000
+64.4%
688,945
+13.0%
0.00%
+50.0%
Q4 2017$1,634,000
+24.5%
609,849
+48.3%
0.00%0.0%
Q3 2017$1,312,000
+189.6%
411,149
+200.7%
0.00%
+100.0%
Q2 2017$453,000
-9.6%
136,745
+14.6%
0.00%0.0%
Q1 2017$501,000119,3450.00%
Other shareholders
CTI BIOPHARMA CORP shareholders Q1 2019
NameSharesValueWeighting ↓
Legal & General Group Plc 9,340$84,9010.00%
UBS ASSET MANAGEMENT AMERICAS INC 92,700$389,3400.00%
FNY Investment Advisers, LLC 20$00.00%
View complete list of CTI BIOPHARMA CORP shareholders